Evidence map›Paper›PMID 31167970›Full record

ArticleJCI insight2019

The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance.

Melinde Wijers, Paolo Zanoni, Nalan Liv, Dyonne Y Vos, Michelle Y Jäckstein, Marieke Smit, Sanne Wilbrink, Justina C Wolters, Ydwine T van der Veen, Nicolette Huijkman and 9 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. COPI Coatomer Regulates Several Steps of HDL Metabolism.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Variants inGenetics in medicine open · 2025
    Article
  8. Article
  9. Article
  10. Mechanism of the Regulation of Plasma Cholesterol Levels by PI(4,5)PAdvances in experimental medicine and biology · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Taking One Step Back in Familial Hypercholesterolemia:Arteriosclerosis, thrombosis, and vascular biology · 2020
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Melinde WijersDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Paolo ZanoniInstitute for Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland; Centre for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
Nalan LivSection Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Dyonne Y VosDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Michelle Y JäcksteinDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Marieke SmitDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Sanne WilbrinkDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Justina C WoltersDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Ydwine T van der VeenDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Nicolette HuijkmanDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Daphne DekkerDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Niels KloosterhuisDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Theo H van DijkLaboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Daniel D BilladeauDepartment of Immunology and Biochemistry, Division of Oncology Research, Mayo Clinic, Rochester, New York, USA.
Folkert KuipersDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Judith KlumpermanSection Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Arnold von EckardsteinInstitute for Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland; Centre for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
Jan Albert KuivenhovenDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Bart van de SluisDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
University Medical Center Groningen · NLUniversity of Zurich · CHUtrecht University · NLMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evolutionary conserved Wiskott-Aldrich syndrome protein and SCAR homolog (WASH) complex is one of the crucial multiprotein complexes that facilitates endosomal recycling of transmembrane proteins. Defects in WASH components have been associated with inherited developmental and neurological disorders in humans. Here, we show that hepatic ablation of the WASH component Washc1 in chow-fed mice increases plasma concentrations of cholesterol in both LDLs and HDLs, without affecting hepatic cholesterol content, hepatic cholesterol synthesis, biliary cholesterol excretion, or hepatic bile acid metabolism. Elevated plasma LDL cholesterol was related to reduced hepatocytic surface levels of the LDL receptor (LDLR) and the LDLR-related protein LRP1. Hepatic WASH ablation also reduced the surface levels of scavenger receptor class B type I and, concomitantly, selective uptake of HDL cholesterol into the liver. Furthermore, we found that WASHC1 deficiency increases LDLR proteolysis by the inducible degrader of LDLR, but does not affect proprotein convertase subtilisin/kexin type 9-mediated LDLR degradation. Remarkably, however, loss of hepatic WASHC1 may sensitize LDLR for proprotein convertase subtilisin/kexin type 9-induced degradation. Altogether, these findings identify the WASH complex as a regulator of LDL as well as HDL metabolism and provide in vivo evidence for endosomal trafficking of scavenger receptor class B type I in hepatocytes.

Indexed as

Microfilament ProteinsVesicular Transport ProteinsAnimalsCholesterol, HDLCholesterol, LDLFemaleLiverMaleMiceMice, Inbred C57BLMice, TransgenicScavenger Receptors, Class BCholesterol, HDLCholesterol, LDLMicrofilament ProteinsScarb1 protein, mouseScavenger Receptors, Class BVesicular Transport ProteinsWASH protein, mouseAtherosclerosisCardiovascular diseaseCholesterolHepatologyMetabolism

Identifiers

PMID31167970
PMCPMC6629119
OpenAlexW2948659925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.